ACE2	Angiotensin-Converting Enzyme 2
AF	Atrial Fibrillation
AGEs	Advanced Glycation End-Products
ALP	Alkaline Phosphatase
ARBs	Angiotensin Receptor Blockers
ASCVD	Atherosclerotic Cardiovascular Disease
AT1R	Angiotensin II Type 1 Receptor
BIA	Bioelectrical Impedance Analysis
BMI	Body Mass Index
BMD	Bone Mineral Density
BMPs	Bone Morphogenetic Proteins
CHF	Chronic Heart Failure
CKD	Chronic Kidney Disease
CV	Cardiovascular
CVD	Cardiovascular Disease
DXA	Dual-Energy X-ray Absorptiometry
ECG	Electrocardiogram
eGFR	Estimated Glomerular Filtration Rate
EMA	European Medicines Agency
FDA	U.S. Food and Drug Administration
FGF-23	Fibroblast Growth Factor 23
FLS	Fracture Liaison Service
FRAX	Fracture Risk Assessment Tool
GLP-1RAs	Glucagon-Like Peptide-1 Receptor Agonists
HF	Heart Failure
HERS	Heart and Estrogen/progestin Replacement Study
HRT	Hormone Replacement Therapy
hs-CRP	High-sensitivity C-Reactive Protein
ICOPE	Integrated Care for Older People
IOF	International Osteoporosis Foundation
IL-1β	Interleukin-1 beta
IL-6	Interleukin-6
M-CSF	Macrophage Colony-Stimulating Factor
MI	Myocardial Infarction
MR	Mineralocorticoid Receptor
OPG	Osteoprotegerin
PPARγ	Peroxisome Proliferator-Activated Receptor gamma
PTH	Parathyroid Hormone
PTH1R	Parathyroid Hormone Receptor 1
RAAS	Renin–Angiotensin–Aldosterone System
RAGE	Receptor for Advanced Glycation End-Products
RANK	Receptor Activator of Nuclear Factor κB
RANKL	Receptor Activator of Nuclear Factor κB Ligand
RCTs	Randomized Controlled Trials
ROS	Reactive Oxygen Species
SGLT2	Sodium–Glucose Cotransporter 2
T1DM	Type 1 Diabetes Mellitus
T2DM	Type 2 Diabetes Mellitus
TBS	Trabecular Bone Score
TZDs	Thiazolidinediones
VSMCs	Vascular Smooth Muscle Cells
VTE	Venous Thromboembolism
WHO	World Health Organization